Connect with us


Germany recommends against giving Oxford-AstraZeneca vaccine to over 65s – Sydney Morning Herald

Germany’s vaccine committee says there is not enough trial data available to support approving the jab for those aged over 65.



The experts endorsed the vaccines rollout for people aged 18 to 64.
The European Unions drug regulator, the European Medicines Agency, will hand down its verdict on the vaccine on Friday.
Australia has rights to 53.8 million doses of the vaccine developed by AstraZeneca and the University of Oxford, representing the bulk of its initial portfolio.
The Therapeutic Goods Administration (TGA) has also been scrutinising AstraZenecas trial data ahead of an expected decision in February on whether to grant…

Click here to view the original article.